SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michaela A Stoffer, Monika M Schoels, Josef S Smolen, Daniel Aletaha, Ferdinand C Breedveld, Gerd Burmester, Vivian Bykerk, Maxime Dougados, Paul Emery, Boulos Haraoui, Juan Gomez-Reino, Tore K Kvien, Peter Nash, Victoria Navarro-Compán, Marieke Scholte-Voshaar, Ronald van Vollenhoven, Désirée van der Heijde, Tanja A Stamm, Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update, Annals of the Rheumatic Diseases, 2016, 75, 1, 16

    CrossRef

  2. 2
    Laura M. M. Steunebrink, Harald E. Vonkeman, Peter M. ten Klooster, Monique Hoekstra, Piet L. C. M. van Riel, Mart A. F. J. van de Laar, Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry, Clinical Rheumatology, 2016,

    CrossRef

  3. 3
    Eugene V McCloskey, Nicholas C Harvey, John A Kanis, Can we treat to target in osteoporosis?, International Journal of Clinical Rheumatology, 2015, 10, 1, 1

    CrossRef

  4. 4
    Nasir Wabe, Michael J Sorich, Mihir D Wechalekar, Leslie G Cleland, Leah McWilliams, Anita Lee, Llewellyn Spargo, Robert G Metcalf, Cindy Hall, Susanna M Proudman, Michael D Wiese, Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years, Arthritis Research & Therapy, 2015, 17, 1

    CrossRef

  5. 5
    E. L. Nasonov, D. E. Karateev, Does Russia need a treat-to-target initiative?, Rheumatology, 2015, 54, 3, 381

    CrossRef

  6. 6
    Eric D. Newman, Virginia Lerch, Jon Billet, Andrea Berger, H. Lester Kirchner, Improving the Quality of Care of Patients With Rheumatic Disease Using Patient-Centric Electronic Redesign Software, Arthritis Care & Research, 2015, 67, 4
  7. 7
    P. M. ten Klooster, H. E. Vonkeman, M. A. H. Oude Voshaar, L. Siemons, P. L. C. M. van Riel, M. A. F. J. van de Laar, Predictors of satisfactory improvements in pain for patients with early rheumatoid arthritis in a treat-to-target study, Rheumatology, 2015, 54, 6, 1080

    CrossRef

  8. 8
    Anna-Birgitte Aga, Elisabeth Lie, Till Uhlig, Inge Christoffer Olsen, Ada Wierød, Synøve Kalstad, Erik Rødevand, Knut Mikkelsen, Tore K Kvien, Espen A Haavardsholm, Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010, Annals of the Rheumatic Diseases, 2015, 74, 2, 381

    CrossRef

  9. 9
    Santos Castañeda, Juan C. López Robledillo, ¿Es la reumatología una especialidad sostenible?, Reumatología Clínica, 2014, 10, 2, 66

    CrossRef

  10. 10
    Inger L Meek, Harald E Vonkeman, Mart AFJ van de Laar, Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature, BMC Musculoskeletal Disorders, 2014, 15, 1, 142

    CrossRef

  11. 11
    Peter P Cheung, Laure Gossec, Clinical measurement of disease activity in rheumatoid arthritis: why, how and utility of patient self-assessment, International Journal of Clinical Rheumatology, 2014, 9, 3, 327

    CrossRef

  12. 12
    Liseth Siemons, Peter M. ten Klooster, Harald E. Vonkeman, Cees A. W. Glas, Mart A. F. J. de Laar, Distinct Trajectories of Disease Activity Over the First Year in Early Rheumatoid Arthritis Patients Following a Treat-to-Target Strategy, Arthritis Care & Research, 2014, 66, 4
  13. 13
    Santos Castañeda, Juan C. López Robledillo, Is Rheumatology a Sustainable Specialty?, Reumatología Clínica (English Edition), 2014, 10, 2, 66

    CrossRef

  14. 14
    Kabita Nanda, Carol Ann Wallace, The future of treatment for juvenile idiopathic arthritis, International Journal of Clinical Rheumatology, 2014, 9, 2, 135

    CrossRef

  15. 15
    T. Lequerré, G. Avenel, O. Vittecoq, Actualités thérapeutiques dans la polyarthrite rhumatoïde, La Revue de Médecine Interne, 2013, 34, 12, 754

    CrossRef